MedTrace Logo

The Effect of High Dose Arginine Infusion on Hemodynamic and Peripheral Microcirculation

NCT01682889 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2012-09-11

No results posted yet for this study

Summary

The aim of this study was to investigate the effect of a 24- hrs L-arginine infusion on hemodynamic and on parameters of microcirculation in patients with peripheral arterial occlusive disease (PAOD).

Conditions

  • Peripheral Arterial Occlusive Disease

Interventions

DIETARY_SUPPLEMENT

Arginine

L-arginine-hydrochlorid (0.35 g/kg body weight) intravenously for 24 hours

DIETARY_SUPPLEMENT

Placebo

NaCl 0.9% intravenously for 24h

Sponsors & Collaborators

  • Medical Scientific Fund of the Mayor of Vienna

    lead OTHER

Principal Investigators

  • Jörg Michael Hiesmayr, Prof. Dr. · Medical University of Vienna

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
55 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2008-12-31
Completion
2012-01-31

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01682889 on ClinicalTrials.gov